Page last updated: 2024-09-04

alpinetin and Osteolysis

alpinetin has been researched along with Osteolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, W; Huang, L; Lian, H; Liang, J; Liu, Q; Su, Y; Wang, H; Wei, L; Xu, J; Zhao, J	1

Other Studies

1 other study(ies) available for alpinetin and Osteolysis

Article	Year
Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway. Pharmacological research, 2022, Volume: 184 Topics: Animals; Bone Density Conservation Agents; Cell Differentiation; Flavanones; Glycogen Synthase Kinase 3; Inflammation; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Macrophage Colony-Stimulating Factor; Mice; NF-E2-Related Factor 2; NF-kappa B; Osteoclasts; Osteolysis; Oxidants; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha	2022

Article

Year

Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway.

Pharmacological research, 2022, Volume: 184

Topics: Animals; Bone Density Conservation Agents; Cell Differentiation; Flavanones; Glycogen Synthase Kinase 3; Inflammation; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Macrophage Colony-Stimulating Factor; Mice; NF-E2-Related Factor 2; NF-kappa B; Osteoclasts; Osteolysis; Oxidants; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha

2022